Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Accumulated Expenses (2016 - 2023)

Historic Accumulated Expenses for Select Medical Holdings (SEM) over the last 15 years, with Q4 2023 value amounting to $157.7 million.

  • Select Medical Holdings' Accumulated Expenses rose 468.03% to $157.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $157.7 million, marking a year-over-year increase of 468.03%. This contributed to the annual value of $157.7 million for FY2023, which is 468.03% up from last year.
  • Per Select Medical Holdings' latest filing, its Accumulated Expenses stood at $157.7 million for Q4 2023, which was up 468.03% from $154.7 million recorded in Q3 2023.
  • In the past 5 years, Select Medical Holdings' Accumulated Expenses registered a high of $170.3 million during Q3 2019, and its lowest value of $124.1 million during Q4 2019.
  • Its 5-year average for Accumulated Expenses is $144.7 million, with a median of $147.1 million in 2019.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 2800.4% in 2019, then skyrocketed by 1778.63% in 2021.
  • Quarter analysis of 5 years shows Select Medical Holdings' Accumulated Expenses stood at $124.1 million in 2019, then increased by 7.01% to $132.8 million in 2020, then grew by 8.46% to $144.0 million in 2021, then rose by 4.61% to $150.7 million in 2022, then increased by 4.68% to $157.7 million in 2023.
  • Its last three reported values are $157.7 million in Q4 2023, $154.7 million for Q3 2023, and $159.2 million during Q2 2023.